$BIVI what a difference it can make to have a strong ceo: Cuong Do (president & ceo): Former President of Samsung Global Strategy Group and former Chief Strategy Officer for Merck - expect the coming 14 days to be really exciting !!

But doesnt change the fact that we have a very safe and effective drug for alz, much better than competitors with more favorable sub group data likely to follow soon.

$AVXL patients and special interest groups will come to Anavex wanting Blarcamesine! !

Sub group analysis for 50 mg dosing is remarkable.

I think certainly the patient groups will be very interested.

Do not forget they met all endpoints for the 2 groups COMBINED!

$AVXL importantly there a so-called superresponders in the blacarmesine treatment group, they improved in cognition score and these are 84% more than observed without that treatment.

Patient advocate groups will push for approval! !

And these posters are not child’s play they’re very detailed - they pack a lot of information onto one poster so a small group of people must have the results.

What a group, a round of applause in order for the guys/gals who helped make this happen.

Come be part of a friendly group!

Has a great group of retail investors and almost no resistance.

$BLUE great presentation, this was my first time hearing the leadership group speak and I was impressed.